{"text": "This is a single group , open - label safety and efficacy extension trial with a one year treatment period .Patient - specific biomarkers of disease progression , CSF biomarkers of oxidative stress , longitudinal neuroimaging including quantitative measures of CNS tissue destruction and clinical data will be collected as in the randomized study .", "label": "", "metadata": {}, "score": "21.28696"}
{"text": "Both clinical dogma and the societal perspective on costs encourage a diagnostic strategy that combines a high yield with low burden and costs .The aim of the present study was to assess the incremental value of MRI and CSF biomarker analysis after the administration of a simple memory test in the differential diagnosis of patients with MCI .", "label": "", "metadata": {}, "score": "23.242624"}
{"text": "However , the biomarkers did not easily fit into a simple categorical structure and hence we abandoned this approach .However , in the majority of included longitudinal studies there was a clear change in the clinical measures used between time points , making this hypothesis unlikely .", "label": "", "metadata": {}, "score": "23.832893"}
{"text": "This heterogeneity made quantitative synthesis of the extracted data impossible .Looking at the data however , no single biomarker investigated stands out amongst the others as a good candidate for further investigation in a longitudinal study .", "label": "", "metadata": {}, "score": "26.121145"}
{"text": "In addition , we aimed to critique data from identified disease progression biomarker studies relating to study design , participant characteristics , and statistical analyses undertaken , in order to produce guidelines for future studies .", "label": "", "metadata": {}, "score": "27.6148"}
{"text": "Some of the lessons of this systematic review , in particular the necessity for longitudinal studies measuring putative biomarkers and clinical measures several times over several years , have begun to be realised by some researchers and have started to be put into practice .", "label": "", "metadata": {}, "score": "27.74028"}
{"text": "For CSF , the added value was less clear , since the model using the continuous variables did not significantly improve after adding CSF to the RAVLT results .", "label": "", "metadata": {}, "score": "27.851028"}
{"text": "Moreover , the identification of a biomarker was not the primary aim of many studies included in this review but rather a by - product of another study .", "label": "", "metadata": {}, "score": "27.946203"}
{"text": "An understanding of the influence of confounding factors on the biomarker will aid sample size calculations , and allow a rigorous analysis of the final study results by adjusting for these factors .", "label": "", "metadata": {}, "score": "28.281712"}
{"text": "Before proceeding it must be confirmed that such specific imaging biomarkers can be measured with a reliable degree of consistency across different centres , which may have different imaging equipment and software , otherwise the putative biomarker is likely to be of limited use .", "label": "", "metadata": {}, "score": "28.506079"}
{"text": "A potential solution to these problems is the use higher levels of statistical modelling , for example linear mixed models which can be used to test for linear relationships [ 28 ] .", "label": "", "metadata": {}, "score": "28.512701"}
{"text": "Ideally , biomarker studies should be large enough and use broad enough inclusion criteria to capture this heterogeneity and identify the utility of the biomarker in different subgroups of patients .", "label": "", "metadata": {}, "score": "29.020561"}
{"text": "We found insufficient evidence to recommend the use of any biomarker for disease progression in PD clinical trials , which may simply reflect the poor quality of research in this area .", "label": "", "metadata": {}, "score": "29.164967"}
{"text": "However , the literature in this area has never been brought together systematically .We , therefore , aimed to undertake a systematic review to assess what potential surrogate biomarkers for disease progression ( motor and non - motor ) in PD exist , whether any meet the criteria for use in clinical trials , and if not which looks most promising .", "label": "", "metadata": {}, "score": "29.285976"}
{"text": "When considered as single tests , a short memory test , MRI and CSF biomarker analysis all perform at a comparable level , independent of the statistical analysis used .", "label": "", "metadata": {}, "score": "29.334984"}
{"text": "Researchers doing clinical trials with patients in early stages of disease are realizing that they need to use biomarkers , though none have been formally validated .", "label": "", "metadata": {}, "score": "29.746294"}
{"text": "In order to improve future studies , we therefore suggest a provisional ' roadmap ' for conducting biomarker studies in this area , detailed in Figure 2 .", "label": "", "metadata": {}, "score": "29.746994"}
{"text": "These include long - term follow up studies of placebo - treated and active - agent treated patients looking for ongoing divergence , measuring outcomes following a wash - out period [ 2 , 3 ] , and delayed start trial design [ 4 ] .", "label": "", "metadata": {}, "score": "29.912796"}
{"text": "Studies of static predictive biomarkers ( e.g. genetic markers ) which try to anticipate the future rate of disease progression were excluded .A useful biomarker for clinical trials needs to be dynamic - changing with disease progression .", "label": "", "metadata": {}, "score": "29.965508"}
{"text": "Several included studies measured a large number of variables and then calculated multiple individual correlation coefficients and significance values .This sequential testing of multiple variables makes it more likely that a significant correlation will be found simply by chance .", "label": "", "metadata": {}, "score": "30.246078"}
{"text": "CSF A\u03b2 is being used as a biomarker for the drug 's potential clinical actions , but the correlation between A\u03b2 concentration and cognitive function is not proven .", "label": "", "metadata": {}, "score": "30.265776"}
{"text": "Objectives To assess the incremental value of MRI and cerebrospinal fluid ( CSF ) analysis after a short memory test for predicting progression to Alzheimer 's disease from a pragmatic clinical perspective .", "label": "", "metadata": {}, "score": "30.296207"}
{"text": "The use of appropriate statistical techniques should reduce the chance of type I and type II errors , and thereby allow sensible conclusions to be drawn about the efficacy of biomarkers for disease progression .", "label": "", "metadata": {}, "score": "30.601051"}
{"text": "It will also provide ( for the subgroup of subjects who were originally randomized to idebenone ) longitudinal CSF samples on idebenone therapy ( collected 2 years apart ) .", "label": "", "metadata": {}, "score": "30.650255"}
{"text": "In keeping with this fairly long duration of disease most included patients were already on treatment at baseline , and had moderate disease severity scores .", "label": "", "metadata": {}, "score": "30.702095"}
{"text": "Cross - sectional studies .Additional file 4 demonstrates the vast array of putative biomarkers which have been examined in cross - sectional studies , and the large number of clinical measures used to try to draw associations with them .", "label": "", "metadata": {}, "score": "30.828312"}
{"text": "However , this again introduces repeated testing , increasing the likelihood of finding a significant association by chance .It also takes no account of missing data , common in longitudinal studies due to deaths , loss to follow - up or withdrawal from the study .", "label": "", "metadata": {}, "score": "30.852219"}
{"text": "There is currently no evidence to suggest what the minimum duration of a surrogate outcome biomarker study should be .Undoubtedly it needs to be long enough for a clinically significant change in the criterion , used to draw associations with the putative biomarker , to be observed .", "label": "", "metadata": {}, "score": "31.054438"}
{"text": "No restriction was made on the grounds of participant 's age , disease duration , or drug treatment .Studies which investigated the efficacy of using a biomarker , including ( but not restricted to ) imaging , blood tests , tests of CSF and neurophysiological tests , to investigate disease progression in Parkinson 's disease were included .", "label": "", "metadata": {}, "score": "31.355059"}
{"text": "Following completion of all these preliminary steps it should then be possible to undertake a power calculation to determine an appropriate sample size for the biomarker study .", "label": "", "metadata": {}, "score": "31.4479"}
{"text": "Unfortunately it appeared that many of the studies included in this review had been conducted without input from an experienced statistician .Whilst a detailed review of the appropriate statistical techniques to use in disease progression biomarker studies is beyond the scope of this review , we wish to make a few key points .", "label": "", "metadata": {}, "score": "31.574656"}
{"text": "However , in general , the effect of biomarker assessments in subsequent studies and daily practice tends to be lower than in the initial reports fuelling current recommendations .", "label": "", "metadata": {}, "score": "31.754684"}
{"text": "Secondly , the reliability of a putative biomarker must be established by demonstrating the reproducibility of its measurement in a single centre by different personnel , and between different centres .", "label": "", "metadata": {}, "score": "32.363617"}
{"text": "Ultimately , it may stimulate a more individualised approach in the diagnostic evaluation of older persons with cognitive complaints .Independent studies on the diagnostic value and cost - effectiveness of an individualised diagnostic approach in more diverse cohorts with cognitive complaints are warranted .", "label": "", "metadata": {}, "score": "32.50288"}
{"text": "The present analysis does , however , provide proof of the general principle that in patients with cognitive complaints , cheap and relatively simple clinical examinations can importantly reduce the incremental value of subsequent invasive , burdensome , expensive and time - consuming technical investigations .", "label": "", "metadata": {}, "score": "32.50996"}
{"text": "As we aimed to produce a comprehensive review and detect any evidence of the utility of a putative biomarker , we set no study quality threshold .", "label": "", "metadata": {}, "score": "32.620113"}
{"text": "Ideally to be a useful biomarker for neuroprotective clinical trials the biomarker should not be influenced by symptomatic treatment .This would simplify trial design meaning patients on and off treatment could be recruited and would mean those going on to treatment would not have to be censored .", "label": "", "metadata": {}, "score": "32.696365"}
{"text": "Whilst cross - sectional studies formed the majority of articles included in this systematic review , a cross - sectional design is not suitable to examine for a relationship between a change in a clinical measure and the change in a biomarker over time within individual patients with PD .", "label": "", "metadata": {}, "score": "32.800625"}
{"text": "As studies get smaller it becomes increasingly likely that potentially significant associations will not be detected , and limits the number of variables that can be included in multivariate analyses without significantly increasing the risk of spurious findings .", "label": "", "metadata": {}, "score": "33.059105"}
{"text": "The reporting of the statistical analyses was also inadequate .In both correlation and regression analyses , hypothesis testing can be undertaken to determine whether a relationship exists in the population as a whole , and confidence intervals calculated to indicate the strength of that relationship .", "label": "", "metadata": {}, "score": "33.169304"}
{"text": "Much work has been undertaken in assessing the validity and reliability of psychometric instruments [ 24 ] , and we would suggest a similar approach here .", "label": "", "metadata": {}, "score": "33.586617"}
{"text": "However , when MRI and CSF testing are evaluated after incorporating the results of a brief test of memory , both diagnostic methods fail to substantially improve diagnostic accuracy when assessed from a clinician 's perspective using the intuitive NRI .", "label": "", "metadata": {}, "score": "33.65466"}
{"text": "We did so to ensure that our review was as inclusive as possible and did not miss potential biomarkers .It does , however , raise the question of the appropriateness of studies with an alternative primary aim ( for example , drug development ) of undertaking these additional , usually cross - sectional , analyses to produce information regarding such associations .", "label": "", "metadata": {}, "score": "33.95371"}
{"text": "Data on the study design , participants and diagnostic test procedures provided by ADNI were of sufficient quality to allow for a diagnostic test accuracy study .", "label": "", "metadata": {}, "score": "34.044724"}
{"text": "Our analysis from a pragmatic clinical point of view does not warrant any conclusion concerning the value of MRI or CSF - analysis for research into disease mechanisms in dementia .", "label": "", "metadata": {}, "score": "34.47378"}
{"text": "In the near term , the findings could be useful in a research context , allowing scientists to track the effects of potential beta - amyloid lowering treatments in clinical trials .", "label": "", "metadata": {}, "score": "34.518883"}
{"text": "Data as presented here that specify how new information affects the diagnostic accuracy based on clinical information from other sources can be a first step towards a more rigorous evaluation of new diagnostic methods .", "label": "", "metadata": {}, "score": "34.558258"}
{"text": "This study will provide open - label idebenone for patients with PP - MS , previously randomized to idebenone or to placebo in the blinded phase of IPPoMS .", "label": "", "metadata": {}, "score": "35.15322"}
{"text": "Data synthesis .Given the likelihood that included studies would examine the relationship of multiple different putative biomarkers with multiple different clinical measures of disease severity , we were aware that any data synthesis would be qualitative in nature .", "label": "", "metadata": {}, "score": "35.248436"}
{"text": "\" These measures hold potential for identifying individuals with AD pathology before cognitive symptoms , improving the accuracy of clinical diagnosis of AD and facilitating the testing of future therapies . \"", "label": "", "metadata": {}, "score": "35.33062"}
{"text": "The firms believe that they can persuade the FDA to accept the NTB as an alternative to the ADAS - cog .The researchers hope that these results will generate the funding for additional trials .", "label": "", "metadata": {}, "score": "35.376755"}
{"text": "An alternative approach , the focus of much primary research , is the use of a surrogate outcome biomarker as an endpoint in neuroprotective clinical trials .", "label": "", "metadata": {}, "score": "35.636517"}
{"text": "Many studies also omitted to report precise significance values , instead simply giving results descriptive in the text .If due to pressure of space the actual results of statistical analyses can not be fully included in a journal article then data should be provided as an additional online resource .", "label": "", "metadata": {}, "score": "35.724735"}
{"text": "( 3 )The RAVLT had one of the largest effect sizes in our previous analysis on differential diagnostic test characteristics in different age groups performed in the same dataset .", "label": "", "metadata": {}, "score": "35.740463"}
{"text": "Their study describes the first model that allows investigators to consider ... read more .Is it possible to create public policy that will rein in ... read more .", "label": "", "metadata": {}, "score": "35.7791"}
{"text": "Retrospective analysis of CSF biomarkers and clinical data .SETTING : .An academic Alzheimer disease research center .PARTICIPANTS : .Research volunteers in a longitudinal study of aging and cognition .", "label": "", "metadata": {}, "score": "35.845955"}
{"text": "Moreover , in the ADNI cohort exclusion of patients with cerebrovascular disease , space - occupying lesions , evidence of infections or other signs of systemic disease may also have affected the interpretation of MRI and CSF test results .", "label": "", "metadata": {}, "score": "35.876812"}
{"text": "Similarly , a third of studies failed to mention whether inclusion and exclusion criteria were applied .Of those providing this information over half applied moderately to severely restrictive inclusion / exclusion criteria .", "label": "", "metadata": {}, "score": "35.968395"}
{"text": "Unfortunately at present there is not a single accepted surrogate outcome biomarker for any neurodegenerative disorder .Table 1 outlines the ideal characteristics of a surrogate biomarker for disease progression in PD .", "label": "", "metadata": {}, "score": "36.02258"}
{"text": "Similarly the majority of cross - sectional studies simply used basic correlation analysis rather than more complex statistical techniques .Overall the standard of reporting results from statistical analyses in the included longitudinal and cross - sectional studies was poor .", "label": "", "metadata": {}, "score": "36.064926"}
{"text": "We found insufficient evidence to support the use of any biomarker to measure motor or non - motor disease progression in PD clinical trials .It has also proven difficult to determine which of the current candidate biomarkers merits selection over the others for further investigation .", "label": "", "metadata": {}, "score": "36.115753"}
{"text": "Unfortunately none of the 163 studies treated as cross - sectional in this review included an analysis of the acceptability of the test in question to the patients .", "label": "", "metadata": {}, "score": "36.144615"}
{"text": "The researchers combined high - tech brain imaging with measurement of beta - amyloid protein fragments in cerebrospinal fluid ( CSF ) .They found that greater amounts of beta - amyloid containing plaques in the brain were associated with lower levels of a specific protein fragment , amyloid - beta 1 - 42 , in CSF .", "label": "", "metadata": {}, "score": "36.15535"}
{"text": "Strengths and limitations .A major strength of our study is that it combines data on clinical characteristics , neuroimaging and CSF biomarkers from a cohort of older persons who were all examined in the same way according to a well - defined protocol .", "label": "", "metadata": {}, "score": "36.205864"}
{"text": "The company plans to do so in further trials , but has yet to decide which type of imaging , and whether all participants or a subgroup will receive it , he added .", "label": "", "metadata": {}, "score": "36.26411"}
{"text": "Strengths and limitations of this study .Major strengths are the well characterised and relatively large sample size and the innovative methodological approach from a radically pragmatic clinical perspective using the NRI .", "label": "", "metadata": {}, "score": "36.296394"}
{"text": "On the biomarker front , PBT2 showed statistically significant reduction of A\u03b242 in the cerebrospinal fluid ( CSF ) in a dose - dependent manner .", "label": "", "metadata": {}, "score": "36.45179"}
{"text": "However , the models also ensure that those with incomplete data do not influence the results as greatly as those with complete data .Using these models , a time effect on the repeated measure , independent from disease progression , is allowed for .", "label": "", "metadata": {}, "score": "36.488274"}
{"text": "Such studies could be run alongside other studies ( e.g. long - term prognostic studies or clinical trials ) but only if appropriately planned and funded .", "label": "", "metadata": {}, "score": "36.528778"}
{"text": "To allow their use in clinical trials surrogate outcome biomarkers must have a strong association with a clinical endpoint or outcome known to measure the effect of a therapeutic intervention on disease progression , for which the biomarker can act as a substitute .", "label": "", "metadata": {}, "score": "36.823135"}
{"text": "Future studies should justify their inclusion and exclusion criteria , and try to minimise the latter to avoid limiting the generalisability of their results or highlight their limited generalisability .", "label": "", "metadata": {}, "score": "36.893078"}
{"text": "It also has the advantage of allowing the inclusion of factors which may affect the relationship between the variables of interest , and adjusts for these potential confounders .", "label": "", "metadata": {}, "score": "37.183216"}
{"text": "This extensive systematic review has highlighted the methodological , statistical and reporting flaws of studies examining biomarkers for disease progression in Parkinson 's disease .It is clear that continuing to publish small cross - sectional studies in this area is unlikely to yield significant results .", "label": "", "metadata": {}, "score": "37.327385"}
{"text": "The majority of the imaging studies found no relationship between imaging parameters and clinical measures of disease severity , as illustrated in Table 5 .Those which did report a significant relationship were single studies , examining specific brain regions , with results which have not been replicated by another group .", "label": "", "metadata": {}, "score": "37.340218"}
{"text": "Patients who were previously enrolled in the IPPoMS ( Protocol Number 09-N-0197 ) will be invited to participate in the trial .The same idebenone dose used in the randomized clinical trial ( 2250 mg / day ) will be used in this study .", "label": "", "metadata": {}, "score": "37.526917"}
{"text": "Whilst eight ( 40 % ) longitudinal studies did not detail the treatment status of patients at baseline , three studies [ 20 - 22 ] did look at the effect of drug therapy on the biomarker under examination .", "label": "", "metadata": {}, "score": "37.66771"}
{"text": "Safety will be assessed by monitoring for study - related toxicity .Efficacy will be assessed by measuring the total number of CD34 + cells , the ability of these cells to be transduced with a recombinant lentivirus vector for beta - globin , and the ability of these cells to engraft immunodeficient mice .", "label": "", "metadata": {}, "score": "37.68824"}
{"text": "For instance , if dementia progresses slowly among all patients in a trial , a larger number of participants would be needed to determine if the treatment was effective over a given time period .", "label": "", "metadata": {}, "score": "37.85724"}
{"text": "Official Title : .A Pilot Study to Assess the Safety and Efficacy of G - CSF Mobilization With and Without Hydroxyurea Pretreatment in Adults With Beta Thalassemia Major .", "label": "", "metadata": {}, "score": "37.99067"}
{"text": "The search for new measures , or \" biomarkers , \" to detect Alzheimer 's disease before signs of memory loss appear has advanced an important step in a study by researchers at Washington University and the University of Pittsburgh .", "label": "", "metadata": {}, "score": "38.038185"}
{"text": "In the included longitudinal studies the biomarker and clinical measures were generally only measured twice ( mean 2.2 ( SD 0.4 ) time points ) , which is clearly insufficient to allow the differentiation of a linear from a non - linear association .", "label": "", "metadata": {}, "score": "38.108234"}
{"text": "Conclusions .This study provides new CSF candidate markers associated with progression of disease in ALS .The data suggest that a deficiency of cellular neuroprotective mechanisms ( decrease of sAPP ) is linked to progressive neuro - axonal damage ( increase of NfH SMI35 ) and to progression of disease .", "label": "", "metadata": {}, "score": "38.325886"}
{"text": "Only in this stage of the process , cognitive impairments are presumed to arise .Another important caveat of the present analysis is that the NRI treats false - positive and false - negative results equally .", "label": "", "metadata": {}, "score": "38.366684"}
{"text": "For reasons of typographical clarity not all possible changes of diagnostic category are delineated .Explorative analyses using alternative cut - off points for all the three diagnostic tests did not importantly change our findings on the relative strengths of the resulting NRIs , as can be expected since more sensitive cut - offs by definition lead to reduced specificities and vice versa .", "label": "", "metadata": {}, "score": "38.56176"}
{"text": "The starting point for any biomarker study must be a valid reason for selecting the specific biomarker for investigation , based on the pathophysiology of PD .", "label": "", "metadata": {}, "score": "38.68053"}
{"text": "Design and subjects .This is a case - control study within a prospective cohort study to evaluate the incremental value of MRI and CSF - analysis after a brief memory - test .", "label": "", "metadata": {}, "score": "38.729485"}
{"text": "Background .Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease - modifying effects .", "label": "", "metadata": {}, "score": "38.81976"}
{"text": "All analyses were carried out with PASW V.18.0 .Results .Characteristics of the study sample are specified in table 1 .Cognitive impairment in the patients was mild , as expected in an MCI population .", "label": "", "metadata": {}, "score": "39.00251"}
{"text": "First , we performed univariate Cox regression analyses with the time to diagnosis of dementia as the dependent variable , and RAVLT , entorhinal cortex volume on MRI and p - \u03c4 / A\u03b2 in CSF as covariates , dichotomised at the optimal cut - off values .", "label": "", "metadata": {}, "score": "39.063095"}
{"text": "Without clear reporting of the study methodology , results , and the outcome of statistical analyses , investigators devalue their study and risk it being excluded from future systemic reviews or meta - analyses .", "label": "", "metadata": {}, "score": "39.105434"}
{"text": "CSF analysis of A\u03b2 and phosphorylated \u03c4 ( p - \u03c4 ) in ADNI has been specified previously .16 , 17 We selected one of the CSF - marker profiles ( p - \u03c4 / A\u03b2 ) that was previously shown to distinguish well between AD and controls and patients with MCI who remain stable versus those who progress to AD .", "label": "", "metadata": {}, "score": "39.3004"}
{"text": "CDR - SB for each assessment for the 10 individuals with the highest CSF A\u03b2 42 is shown in Panel B. CSF A\u03b2 42 values were 588 - 1179 pg / ml for this group .", "label": "", "metadata": {}, "score": "39.4844"}
{"text": "When the NRI for all diagnostic measures is calculated in isolation , all diagnostic tests substantially improve diagnostic classification ( table 4 ) .Participants who were incorrectly reclassified to the wrong diagnostic category are taken into account by this method , thus specifying the resulting false -positive and false -negative cases following a diagnostic test .", "label": "", "metadata": {}, "score": "39.651756"}
{"text": "In daily practice , the single test of immediate recall as used in the present analysis will often be insufficient and a more comprehensive examination of affect and cognition will be required in patients representing a broader spectrum of differential diagnoses .", "label": "", "metadata": {}, "score": "39.684914"}
{"text": "We used data on individuals diagnosed with MCI of whom complete data on memory , MRI and CSF test results were available .Participants who used drugs with anticholinergic or narcotic properties were excluded , but the use of a stable dose of cholinesterase inhibitors was allowed .", "label": "", "metadata": {}, "score": "40.275246"}
{"text": "The CSF tau concentration was unchanged in this trial .PBT2 is a second - generation drug derived from clioquinol , a known antibiotic and weak metal chelator .", "label": "", "metadata": {}, "score": "40.29605"}
{"text": "Types of biomarkers investigated .A broad spectrum of different biomarker modalities were investigated in the studies included in this systematic review ( Table 4 ) .", "label": "", "metadata": {}, "score": "40.47664"}
{"text": "The remaining 27 articles had a longitudinal design , but only 20 ( 11 % ) of these attempted to examine for relevant longitudinal relationships between a change in a biomarker and a change in a clinical measure of disease severity .", "label": "", "metadata": {}, "score": "40.53276"}
{"text": "In keeping with this , they also had milder disease at baseline , with significantly better UPDRS ( II ) scores and lower Hoehn and Yahr stages than those in cross - sectional studies .", "label": "", "metadata": {}, "score": "40.540054"}
{"text": "Study Design : The ability of G - CSF to safely and effectively mobilize PBSC in adults with beta thalassemia major will be assessed in 12 splenectomized and 12 non - splenectomized patients .", "label": "", "metadata": {}, "score": "40.603966"}
{"text": "Just because a substance can be measured does not mean an attempt should be made to find an association between that substance and clinical measures of disease severity .", "label": "", "metadata": {}, "score": "40.654503"}
{"text": "In this short study , using CSF biochemistry made sense , since brain imaging probably would not have shown changes this quickly , said Ritchie .", "label": "", "metadata": {}, "score": "40.766026"}
{"text": "Next , the performance of the memory test , MRI and CSF measures were assessed with the NRI which gives the proportion of participants correctly ( re-)classified as either control or case .", "label": "", "metadata": {}, "score": "40.932346"}
{"text": "After the administration of a brief test of memory , MRI or CSF does not substantially affect diagnostic accuracy for Alzheimer 's disease in patients with mild cognitive impairment .", "label": "", "metadata": {}, "score": "41.04691"}
{"text": "Furthermore in 81.4 % of longitudinal correlations and 61.0 % of cross - sectional correlations a P value was not given .No study included in this review detailed confidence intervals for a given correlation coefficient .", "label": "", "metadata": {}, "score": "41.13037"}
{"text": "Although often applied in practice , it is not well known to what extent MRI and cerebrospinal fluid ( CSF ) analysis improve diagnostic accuracy .", "label": "", "metadata": {}, "score": "41.18496"}
{"text": "Since many clinicians find HR from Cox models difficult to interpret and translate into daily practice decisions , we subsequently did the analysis from a clinician 's perspective .", "label": "", "metadata": {}, "score": "41.191864"}
{"text": "Their work , like that of the longitudinal Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) [ 31 ] in Alzheimer 's disease , should mark a major shift in the quality of studies of biomarkers for disease progression , and hopefully lead to advances in this important field .", "label": "", "metadata": {}, "score": "41.328415"}
{"text": "The paper was prepared according to the STARD criteria for diagnostic research papers .All authors have read and approved the final manuscript .Funding No specific funding was obtained for the preparation of this manuscript .", "label": "", "metadata": {}, "score": "41.34602"}
{"text": "Studies comparing the discriminative power of diagnostic measures usually rely on statistical analyses that implicitly treat all potential predictors equally and in parallel , for example , by feeding data on all potential new diagnostic instruments into multivariate statistical models .", "label": "", "metadata": {}, "score": "41.447384"}
{"text": "All participants had a global CDR of 0.5 ( with CDR - SB between 0.5 and 4.5 ) at the assessment before the LP .Slope of CDR - SB over time in biomarker tertiles .", "label": "", "metadata": {}, "score": "41.772034"}
{"text": "Only studies examining for associations between putative biomarkers and global measures of cognition ( e.g. Mini - mental state examination ( MMSE ) [ 14 ] , Cambridge cognitive examination ( CAMCOG [ 15 ] ) ) , rather than individual neuropsychological tests , were included .", "label": "", "metadata": {}, "score": "41.842194"}
{"text": "However , despite stating that this occurred , details of the outcome are not given in the paper ; correlations are simply described with a correlation coefficient ( r value ) and the level of significance ( P value ) .", "label": "", "metadata": {}, "score": "41.8725"}
{"text": "40 ) , cerebrospinal fluid ( CSF ) levels of sAPPa a , sAPP\u00df and neurofilaments ( NfH SMI35 ) were measured by multiplex assay , Progranulin by ELISA .", "label": "", "metadata": {}, "score": "41.88835"}
{"text": "Conclusions and future directions .The present results highlight the importance of the order of tests in evaluating individuals with cognitive complaints .After administration of a brief test of memory , MRI or CSF does not substantially improve diagnostic accuracy in patients with MCI .", "label": "", "metadata": {}, "score": "41.92022"}
{"text": "Were associations between the biomarker and clinical measures of disease severity examined for using appropriate statistical modelling ( e.g. linear mixed modelling ) with adjustment for confounding factors , rather than simply correlation analysis ?", "label": "", "metadata": {}, "score": "42.08773"}
{"text": "It will examine whether serial magnetic resonance imaging ( MRI ) , PET , other biomarkers , and clinical and neuropsychological assessment can be combined to assess mild cognitive impairment and early AD progression .", "label": "", "metadata": {}, "score": "42.224045"}
{"text": "Biomarkers Definitions Working Group : Biomarkers and surrogate endpoints : preferred definitions and conceptual framework .Clin Pharmacol Ther 2001 , 69 ( 3 ) : 89 - 95 .", "label": "", "metadata": {}, "score": "42.49669"}
{"text": "The first four were based on free - text words identified through background reading of relevant review articles .These searches included potential ( [ 1 ] ) blood , ( [ 2 ] ) urine or cerebrospinal fluid ( CSF ) , ( [ 3 ] ) imaging and ( [ 4 ] ) neurophysiological biomarkers .", "label": "", "metadata": {}, "score": "42.836113"}
{"text": "A variety of different PET and SPECT ligands were used .This marked heterogeneity in the studies unfortunately made quantitative synthesis of the extracted data impossible .", "label": "", "metadata": {}, "score": "42.890633"}
{"text": "We subsequently did the analysis using the NRI .Figure 1 shows the ROC curves for the three diagnostic measures .The resulting AUCs and overlapping CIs of the three diagnostic tests illustrate that their performance was largely comparable ( table 3 ) .", "label": "", "metadata": {}, "score": "43.007984"}
{"text": "Limiting enrollment to individuals with CSF A\u03b242 values below a certain cutoff point might ameliorate the difficulties caused by lack of disease progression in some individuals during the trial .", "label": "", "metadata": {}, "score": "43.04023"}
{"text": "Use of correlation analysis in longitudinal studies , where repeated measurements are performed , is inappropriate as this takes no account of the possible covariance between measurements recorded in the same individual .", "label": "", "metadata": {}, "score": "43.080948"}
{"text": "22 The present findings suggest that from a pragmatic perspective , neither MRI nor CSF - analysis does importantly increase diagnostic accuracy for progression to AD in MCI patients , if a brief test of memory is administered first .", "label": "", "metadata": {}, "score": "43.392746"}
{"text": "For example , the study will provide qualitative data on the safety and feasibility of utilizing HU and G - CSF to mobilize stem cells in individuals with beta thalassemia major .", "label": "", "metadata": {}, "score": "43.783283"}
{"text": "Change in CDR - SB over time .In Panel A , data are shown for the 10 individuals with the lowest CSF A\u03b2 42 levels ( actual values were from 182 - 263 pg / ml ) .", "label": "", "metadata": {}, "score": "43.819626"}
{"text": "We then added entorhinal cortex volume on MRI and p - \u03c4 / A\u03b2 in CSF using a stepwise forward procedure in order to determine the effect of each variable on the overall performance of the model .", "label": "", "metadata": {}, "score": "43.865112"}
{"text": "\" This study represents one step in the progress being made toward identifying clinically useful biological measures for AD . \" Both ADRCs are funded by the NIA .", "label": "", "metadata": {}, "score": "43.913315"}
{"text": "We made no restriction on age , disease duration , drug treatment , or study design .We included studies which attempted to draw associations between any tests used to investigate disease progression and any clinical measures of disease progression .", "label": "", "metadata": {}, "score": "43.91954"}
{"text": "Data extraction .Study methods and results were extracted by a single reviewer , and for accuracy this was performed twice .Methodological quality .No validated tool to measure the quality of studies investigating surrogate biomarkers as outcome measures exists .", "label": "", "metadata": {}, "score": "44.063347"}
{"text": "Mean follow - up of patients was 38.9 months ( 5.5 - 75.9 ) .Diagnostic tests .We based our analyses on the three most commonly used diagnostic instruments in cognitive impairment : memory tests , MRI and CSF .", "label": "", "metadata": {}, "score": "44.108574"}
{"text": "CSF biomarker values for each tertile are provided in the legend .Change in psychometric composite score over time in biomarker tertiles .For each individual biomarker , the sample was divided into tertiles ( i.e. , low , middle , and high biomarker groups ) based on a frequency distribution of the baseline biomarker values as in .", "label": "", "metadata": {}, "score": "44.222137"}
{"text": "A Phase I / II clinical trial is being conducted to investigate the safety , therapeutic efficacy and mechanism of action of idebenone in primary - progressive multiple sclerosis ( PP - MS ) patients ( IPPoMS ( Protocol Number 09-N-0197 ) .", "label": "", "metadata": {}, "score": "44.307205"}
{"text": "All test variables were corrected for age , sex and education based on regression weights in the control group as previously described .For each of the three diagnostic measures ( RAVLT , entorhinal cortex volume on MRI and p - \u03c4 / A\u03b2 in CSF ) , we then calculated the ROC curves and the respective AUCs .", "label": "", "metadata": {}, "score": "44.36718"}
{"text": "The primary outcome measure defined in the IPPoMS trial will be also utilized in IPPoMS - E. For patients originally randomized to placebo , patient - specific slopes of disease progression during 2 years of placebo therapy ( as measured by primary and secondary outcomes ) will be compared to patient - specific slopes of disease progression during 1 year of open label idebenone therapy .", "label": "", "metadata": {}, "score": "44.436417"}
{"text": "PubMed View Article .Winogrodzka A , Bergmans P , Booij J , van Royen EA , Janssen AG , Wolters EC : [ 123I]FP - CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early - stage Parkinson 's disease .", "label": "", "metadata": {}, "score": "44.528908"}
{"text": "Statistics .Correlation analysis , a basic statistical method which can be used to examine for a relationship between two variables , was solely used in 75 % ( 15/20 ) of longitudinal studies .", "label": "", "metadata": {}, "score": "44.676544"}
{"text": "As depression in PD is not linked to overall disease progression [ 16 ] and may be commoner at the time of diagnosis [ 17 ] , studies only investigating the relationship between a biomarker and depression were excluded .", "label": "", "metadata": {}, "score": "44.735085"}
{"text": "They also both examined different FDG expression patterns and only found that some ( four out of six ) of these patterns showed a significant association with a change in the motor UPDRS .", "label": "", "metadata": {}, "score": "44.811394"}
{"text": "Acceptable measures included measures of motor or cognitive impairment , disability , handicap , quality of life , and duration of survival .Only studies exploring associations between a biomarker and the total score from a clinical rating scale , rather than its subsections , were included .", "label": "", "metadata": {}, "score": "44.971207"}
{"text": "Special care was taken that the specific clinical test that was evaluated here , the RAVLT , did not play any role in the final diagnostic classification that was used as gold standard in ADNI .", "label": "", "metadata": {}, "score": "45.10495"}
{"text": "Participants may be cognitively normal or have MCI or early AD .Anyone interested in learning more about enrollment in the project may contact the study site closest to them .", "label": "", "metadata": {}, "score": "45.308598"}
{"text": "While this study answered some questions , it has raised questions , also .There is sufficient interest and excitement for larger , longer studies to test for efficacy and determine best dosage , \" says Ritchie .", "label": "", "metadata": {}, "score": "45.42719"}
{"text": "In these cases regression can be used either by including baseline measurements as a covariant in the model , or by converting the pairs of measurements recorded in each individual into the actual change or percentage change from baseline , before using these calculated values in the regression model .", "label": "", "metadata": {}, "score": "45.708958"}
{"text": "View Article .Brooks DJ , Frey KA , Marek KL , Oakes D , Paty D , Prentice R , Shults CW , Stoessl AJ : Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson 's disease .", "label": "", "metadata": {}, "score": "45.75054"}
{"text": "The role of neuroimaging using CT or MRI does remain undisputed in selected patients with suspected cerebrovascular damage and to rule out surgically treatable conditions , which account for up to 1 % of all cases of dementia .", "label": "", "metadata": {}, "score": "46.110573"}
{"text": "Hobart JC , Cano SJ , Zajicek JP , Thompson AJ : Rating scales as outcome measures for clinical trials in neurology : problems , solutions , and recommendations .", "label": "", "metadata": {}, "score": "46.22666"}
{"text": "12883_2012_763_MOESM3_ESM.docx Additional file 3 : Biomarkers examined in longitudinal studies and their relationship with clinical measures of disease severity .( DOCX 67 KB ) .", "label": "", "metadata": {}, "score": "46.307663"}
{"text": "Finally data were extracted from a total of 183 articles .Flow diagram outlying the selection procedure to identify 183 articles included in the systematic review of biomarkers for disease progression in PD .", "label": "", "metadata": {}, "score": "46.67015"}
{"text": "Clinical assessments in PD using scales to measure motor impairment , disability , quality of life , or disease stage scales are affected by symptomatic effects of therapy and are unable to differentiate this effect from disease - modification , at least in the short - term .", "label": "", "metadata": {}, "score": "46.686768"}
{"text": "These visits may be scheduled over multiple days .Participants will provide blood and urine samples .They will also have imaging studies of the brain and spine .", "label": "", "metadata": {}, "score": "46.818756"}
{"text": "Results .183 studies were included : 163 ( 89 % ) cross - sectional , 20 ( 11 % ) longitudinal .The electronic search strategy had a sensitivity of 71.4 % ( 95 % CI 51.1 - 86.0 ) and a specificity of 97.1 % ( 95 % CI 96.5 - 97.7 ) .", "label": "", "metadata": {}, "score": "47.122147"}
{"text": "No statistically significant impact was seen on the ADAS - cog battery after three months of treatment .The researchers did report seeing signs of cognitive improvement as measured by the Neuropsychological Test Battery ( NTB ) .", "label": "", "metadata": {}, "score": "47.142487"}
{"text": "Keywords .Parkinson disease Biomarkers Disease progression Clinical trials Neuroprotective agents .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "47.37256"}
{"text": "Allocation : Non - Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Single Group Assignment Masking : Open Label Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "47.420784"}
{"text": "All the participants had at least one follow - up assessment an average of 3.5 years later .\" The rate of dementia progression was significantly more rapid in individuals with lower baseline cerebrospinal fluid A\u03b242 levels , higher tau or ptau 181 levels or high tau : A\u03b242 ratios , \" the authors write . \"", "label": "", "metadata": {}, "score": "47.440033"}
{"text": "There is no evidence that PBT2 is working in a non - specific manner , \" said Colin Masters , who directs the Mental Health Research Institute of Victoria and is on the Research and Development Advisory Board of Prana .", "label": "", "metadata": {}, "score": "47.496105"}
{"text": "However , correlation is a limited technique to use for this purpose as it only indicates the strength and direction of a relationship between two variables [ 26 ] .", "label": "", "metadata": {}, "score": "47.552303"}
{"text": "In everyday clinical reality , the order and hierarchy of diagnostic information is pivotal .Some information will be readily available during a first appointment , such as findings on brief cognitive testing in patients with suspected dementia .", "label": "", "metadata": {}, "score": "47.75598"}
{"text": "The lower panel shows the net reclassification improvement for the same comparisons as a result of performing a single test ( left ) or on the right , in the grey area , for the MRI and CSF examination , after having incorporated the result of memory testing .", "label": "", "metadata": {}, "score": "47.77021"}
{"text": "Nonetheless the measurement of biomarkers which will be significantly influenced by symptomatic PD therapy ( e.g. plasma dopamine or FDOPA PET uptake ) is unlikely to be helpful , as the biomarker will have very limited clinical utility .", "label": "", "metadata": {}, "score": "47.820587"}
{"text": "This approach would have the advantage of specifically targeting an abnormal process , i.e. , oligomer formation , whereas other approaches to stop the formation of amyloid have to avoid interfering with the normal physiological function of necessary enzymes , such as \u03b3 - secretase , Masters added .", "label": "", "metadata": {}, "score": "47.98817"}
{"text": "Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis .The primary outcome measure that comes out of the pre - determined analysis in the IPPoMS trial will be adopted as primary outcome measure in the IPPoMS - E trial .", "label": "", "metadata": {}, "score": "48.037376"}
{"text": "Likewise , of the 12 non - splenectomized patients , 6 will be treated with HU and G - CSF , and 6 will be treated only with G - CSF .", "label": "", "metadata": {}, "score": "48.071983"}
{"text": "Finding effective treatments for Alzheimer 's disease will likely depend on early identification of patients , according to background information in the article .Barbara J. Snider , M.D. , Ph.D. , and colleagues at Washington University School of Medicine , St. Louis , studied 49 individuals with a diagnosis of very mild dementia of the Alzheimer type .", "label": "", "metadata": {}, "score": "48.159897"}
{"text": "Additional file 3 details the biomarkers examined in the 20 longitudinal studies and their relationship with clinical measures of disease severity .Nine undertook brain SPECT imaging , eight brain PET imaging , one brain MRI , one electrophysiological studies , and one acoustical analysis following a four sentence reading task .", "label": "", "metadata": {}, "score": "48.523026"}
{"text": "As with other imaging modalities we , therefore , felt there was insufficient evidence to single out FDG PET for further investigation .It is possible that the lack of a current biomarker is because no suitable biomarker exists or , at least , no single biomarker given the complexity of the disease .", "label": "", "metadata": {}, "score": "48.6032"}
{"text": "Thus , \" the authors write , \" a more promising approach to the study of dietary factors in AD might entail the use of whole - diet interventions , which have greater ecologic validity and preserve the nutritional milieu in which fat and carbohydrate consumption occurs . \"", "label": "", "metadata": {}, "score": "48.70725"}
{"text": "Alternatively , if these subjects never develop cognitive decline , it is possible that plaque number is not always a predictor of the disease . \"", "label": "", "metadata": {}, "score": "48.74339"}
{"text": "Ability of the obtained stem cells to be transduced with a recombinant lentivirus vector for beta - globin and engraft immunodeficient mice [ Time Frame : Measured at Year 1 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "48.871223"}
{"text": "No Intervention : 2 .Participants will not receive hydroxyurea pretreatment .Detailed Description : .Primary Objective : To determine the safety of PBSC mobilization with G - CSF , with or without HU pretreatment in adults with beta thalassemia major .", "label": "", "metadata": {}, "score": "48.895702"}
{"text": "In general , G - CSF will be administered at 10\u03bcg / kg / day ( 5\u03bcg / kg on a twice a day schedule ) for at least 4 - 5 days before leukapheresis and for 1 - 2 additional days during collections .", "label": "", "metadata": {}, "score": "48.92234"}
{"text": "Longitudinal studies mainly examined the potential of PET and SPECT imaging as a biomarker of disease progression .Table 4 .Types of putative biomarkers for disease progression investigated in the 183 included articles .", "label": "", "metadata": {}, "score": "49.1189"}
{"text": "The purpose of this study is to investigate the safety and feasibility of collecting peripheral blood stem cells ( PBSC ) from individuals with beta thalassemia major .", "label": "", "metadata": {}, "score": "49.16848"}
{"text": "Participants gave informed consent , data are anonymised and risk of identification is minimal . . .The diagnosis of dementia due to Alzheimer 's disease : recommendations from the National Institute on Aging - Alzheimer 's Association workgroups on diagnostic guidelines for Alzheimer 's disease .", "label": "", "metadata": {}, "score": "49.24761"}
{"text": "This was particularly true of many imaging studies , where there was often ambiguity as to whether stated values were mean values or total values for structures represented in both hemispheres .", "label": "", "metadata": {}, "score": "49.361446"}
{"text": "13 , 25 The better CSF test characteristics in early - onset AD may point to a potentially useful indication for CSF analysis in patients with young - onset dementia .", "label": "", "metadata": {}, "score": "49.764236"}
{"text": "None of the studies used duration of survival , or measures of quality of life or handicap as a clinical outcome measure .Characteristics of study participants .", "label": "", "metadata": {}, "score": "49.944702"}
{"text": "Those without PIB binding had the highest levels of CSF amyloid - beta 1 - 42 .No relationship was seen between PIB binding and the other CSF or blood - plasma biomarkers studied , including plasma amyloid - beta 1 - 42 .", "label": "", "metadata": {}, "score": "50.04251"}
{"text": "\" The drug was designed to lower A\u03b2 and we are told in this news release that the higher dose is doing that , although to a modest extent .", "label": "", "metadata": {}, "score": "50.185585"}
{"text": "PubMed View Article .Huang C , Tang C , Feigin A , Lesser M , Ma Y , Pourfar M , Dhawan V , Eidelberg D : Changes in network activity with the progression of Parkinson 's disease .", "label": "", "metadata": {}, "score": "50.347366"}
{"text": "Also , other frequently used indices such as ORs or HRs from multivariate models or an area under the curve ( AUC ) as derived from a receiver - operator characteristics ( ROC ) curve have little intuitive appeal for physicians .", "label": "", "metadata": {}, "score": "50.356598"}
{"text": "PubMed View Article .Bewick V , Cheek L , Ball J : Statistics review 7 : Correlation and regression .Crit Care 2003 , 7 : 451 - 459 .", "label": "", "metadata": {}, "score": "50.38382"}
{"text": "As shown in Figure 1 , the electronic search identified 4080 records .After removing duplicates , 2435 unique records identified by the electronic search were screened , in addition to a further 66 records identified whilst performing the hand search or on reviewing reference lists of relevant review articles and included articles .", "label": "", "metadata": {}, "score": "50.797977"}
{"text": "Researchers have studied biomarkers that offer more reliable diagnosis and , in the ... read more .The researchers behind the study hope that their findings will contribute to a ... read more - The Idebenone in Patients With Primary Progressive Multiple Sclerosis ( IPPoMS ) trial tested a new drug for multiple sclerosis .", "label": "", "metadata": {}, "score": "50.889286"}
{"text": "Symptomatic viral , bacterial , or fungal infection within 6 weeks of eligibility evaluation .Pregnant or breastfeeding .Additional risk factors for thrombosis , including Factor V Leiden ; antiphospholipid antibodies ; and less than 50 % of the lowest normal value for the following procoagulants : antithrombin 3 , protein C , or protein S .", "label": "", "metadata": {}, "score": "50.90676"}
{"text": "The NTB battery comprises 10 cognitive tests to measure early changes in AD , and the Prana researchers added the Trail Making Test to further quantify executive function .", "label": "", "metadata": {}, "score": "50.93167"}
{"text": "PIB makes it possible to see on PET images any areas of the brain with high concentrations of plaques .The researchers also analyzed samples of study participants ' CSF and blood plasma for levels of specific protein fragments , including two forms of beta - amyloid and the protein tau .", "label": "", "metadata": {}, "score": "51.01558"}
{"text": "Included studies were generally poor quality - cross - sectional with small numbers of participants , applying excessive inclusion / exclusion criteria , with flawed methodologies and simplistic statistical analyses .", "label": "", "metadata": {}, "score": "51.033905"}
{"text": "The exception was the Unified Parkinson 's disease rating scale ( UPDRS ) [ 13 ] , where studies examining for relationships to its main constituent parts were included .", "label": "", "metadata": {}, "score": "51.047787"}
{"text": "To provide idebenone to all participants on the IPPoMS trial .To collect data on the safety and effectiveness of idebenone for primary progressive multiple sclerosis .", "label": "", "metadata": {}, "score": "51.30446"}
{"text": "Different diagnostic guidelines from both Europe and the USA recommend that all patients with cognitive impairment should undergo structural imaging .20 European guidelines for the diagnosis of AD identify alterations of A\u03b2 and p - \u03c4 in CSF as supportive for the diagnosis .", "label": "", "metadata": {}, "score": "51.36762"}
{"text": "Calne DB , Snow BJ , Lee C : Criteria for diagnosing Parkinson 's disease .Ann Neurol 1992 , 32 ( Suppl 1 ) : S125-S127 .", "label": "", "metadata": {}, "score": "51.552406"}
{"text": "The memory test , MRI and CSF improved the diagnostic classification by 21 % ( 95 % CI 15.1 to 26.9 ) , 22.1 % ( 95 % CI 16.1 to 28.1 ) and 18.8 % ( 95 % CI 13.1 to 24.5 ) , respectively .", "label": "", "metadata": {}, "score": "51.605453"}
{"text": "All authors had full access to the data and can take responsibility for the integrity of the data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "51.712715"}
{"text": "PLR designed the electronic search strategy and edited the manuscript .PAT and DEW provided statistical expertise with regards to the recommendations for future biomarker studies , and edited the manuscript .", "label": "", "metadata": {}, "score": "51.852097"}
{"text": "All eight articles identified by hand searching ( all cross - sectional ) were included in the final qualitative synthesis .Hand searching .Hand searching to validate the electronic search strategy revealed a sensitivity of 71.4 % ( 95 % CI 51.1 - 86.0 ) and a specificity of 97.1 % ( 95 % CI 96.5 - 97.7 ) .", "label": "", "metadata": {}, "score": "51.957947"}
{"text": "The rate of dementia progression was significantly more rapid in individuals with lower baseline CSF Abeta 42 levels , higher tau or ptau181 levels , or high tau : Abeta 42 ratios .", "label": "", "metadata": {}, "score": "51.99164"}
{"text": "Similarly , the exclusion of AD in participants with memory complaints will offer immense relief and it may invite a search for other conditions that sometimes can be treated effectively , such as depression .", "label": "", "metadata": {}, "score": "52.0095"}
{"text": "MAIN OUTCOME MEASURES : .Baseline CSF levels of Abeta 42 , Abeta 40 , tau , and ptau at threonine 181 ( ptau181 ) and the rate of dementia progression as measured using the CDR sum of boxes ( CDR - SB ) score and psychometric performance .", "label": "", "metadata": {}, "score": "52.02718"}
{"text": "The measurement and collection of data will be performed as in the randomized trial .Quantitative neuroimaging measures of central nervous system ( CNS : i.e. brain and spinal cord ) tissue destruction and clinical and functional measures of neurological disability will be collected every 6 - 12 months .", "label": "", "metadata": {}, "score": "52.113617"}
{"text": "This was a placebo - controlled , randomized , double - blind study in 78 patients with mild to moderate Alzheimer disease who were still functioning at home .", "label": "", "metadata": {}, "score": "52.12641"}
{"text": "McShane LM , Altman DG , Sauerbrei W , Taube SE , Gion M , Clark GM : Reporting recommendations for tumor marker prognostic studies .", "label": "", "metadata": {}, "score": "52.136703"}
{"text": "They believe that the different results of the unhealthy diet in participants with aMCI may be due to the diet 's short duration .\" The therapeutic effects of longer - term dietary intervention may be a promising avenue of exploration , \" the authors conclude . \"", "label": "", "metadata": {}, "score": "52.285316"}
{"text": "Study selection .A single reviewer examined abstracts retrieved by the electronic search to identify articles meriting review in full .Full length articles were then reviewed before data were extracted from relevant papers .", "label": "", "metadata": {}, "score": "52.289383"}
{"text": "Setting Alzheimer Disease Neuroimaging Initiative participants with complete data on neuropsychological assessment , MRI of the brain and CSF analysis .Mean follow - up was 38.9 months ( range 5.5 - 75.9 ) .", "label": "", "metadata": {}, "score": "52.59684"}
{"text": "This study was not designed as a biomarker study , but rather as a drug study to compare the rate of dopamine neuron degeneration after initial treatment with either pramipexole or levodopa in early PD using [ 123 I]\u03b2 - CIT SPECT .", "label": "", "metadata": {}, "score": "52.669178"}
{"text": "Temple RJ : A regulatory authority 's opinion about surrogate endpoints .In Clinical Measurement in Drug Evaluation .Edited by : Nimmo WS , Tucker GT .", "label": "", "metadata": {}, "score": "52.702023"}
{"text": "Negative pregnancy test , if female .Ability to give informed consent and willingness to meet all the expected requirements of the protocol for the duration of the study .", "label": "", "metadata": {}, "score": "52.823036"}
{"text": "CONCLUSIONS : .In individuals with very mild DAT , lower CSF Abeta 42 levels , high tau or ptau181 levels , or high tau : Abeta 42 ratios quantitatively predict more rapid progression of cognitive deficits and dementia .", "label": "", "metadata": {}, "score": "52.972057"}
{"text": "This research was also supported by NIH grants P30 AG010129 , K01 AG030514 , and the Dana Foundation .Competing interests None .Patient consent Obtained .", "label": "", "metadata": {}, "score": "53.004173"}
{"text": "CEC leads Parkinson 's disease aspects of the programme grant , had input into study design , supervised DJMM , and edited the manuscript .All authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "53.318245"}
{"text": "The non - independence of the repeated measures can be accounted for by simply assuming there is a constant correlation for all pairs of measurements in the same individual or by , for example , varying this correlation as measurements become more widely separated by time .", "label": "", "metadata": {}, "score": "53.592102"}
{"text": "\" The search for biomarkers to detect AD and to monitor disease progression was accelerated recently when the NIA , in conjunction with more than a dozen other Federal Government and private - sector organizations , launched the 5-year , $ 60 million Alzheimer 's Disease Neuroimaging Initiative .", "label": "", "metadata": {}, "score": "53.63569"}
{"text": "\u00a9 McGhee et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.New Study Demonstrates Combined Techniques To Detect , Monitor Alzheimer 's Disease .", "label": "", "metadata": {}, "score": "53.96102"}
{"text": "BACKGROUND : .Cerebrospinal fluid ( CSF ) levels of Abeta peptide 1 - 42 ( Abeta 42 ) , tau , and phosphorylated tau ( ptau ) are potential biomarkers of Alzheimer disease .", "label": "", "metadata": {}, "score": "53.982426"}
{"text": "Methods .MEDLINE and EMBASE ( 1950 - 2010 ) were searched using five search strategies .Abstracts were assessed to identify papers meriting review in full .", "label": "", "metadata": {}, "score": "54.040924"}
{"text": "PubMed View Article .Gelb DJ , Oliver E , Gilman S : Diagnostic criteria for Parkinson disease .Arch Neurol 1999 , 56 ( 1 ) : 33 - 39 .", "label": "", "metadata": {}, "score": "54.171345"}
{"text": "\" PBT2 is not a chelator and does n't deplete metal ions in the brain .We believe PBT2 binds to the metal / A\u03b2 complex causing amyloid aggregates to disassociate , releasing metal ions and allowing the brain to clear the toxic A\u03b2 , \" Bush said .", "label": "", "metadata": {}, "score": "54.654312"}
{"text": "PubMed View Article .Mov Disord 2004 , 19 ( 9 ) : 1020 - 1028 .PubMed View Article .Firbank MJ , Molloy S , McKeith IG , Burn DJ , O'Brien JT : Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson 's disease over one year .", "label": "", "metadata": {}, "score": "54.86648"}
{"text": "Although the average follow - up of 38.9 months in the MCI group is considerable , progression to AD can still occur after an even longer time - interval .", "label": "", "metadata": {}, "score": "54.96119"}
{"text": "New research , using artificial intelligence ( AI ) , has analyzed over two million ... read more .A new study looked at the relationship between type 2 diabetes , ... read more .", "label": "", "metadata": {}, "score": "55.012886"}
{"text": "For details of the search strategy please see Additional file 1 .The searches were limited to human studies .Only English language articles were included , due to lack of resources for translation .", "label": "", "metadata": {}, "score": "55.160683"}
{"text": "In the case of FDG PET two papers examined this biomarker and both found a significant association between the change in a FDG PET measure and a change in the motor UPDRS .", "label": "", "metadata": {}, "score": "55.342697"}
{"text": "Clarke CE : Are delayed - start design trials to show neuroprotection in Parkinson 's disease fundamentally flawed ?Mov Disord 2008 , 23 ( 6 ) : 784 - 789 .", "label": "", "metadata": {}, "score": "55.366074"}
{"text": "Toward defining the preclinical stages of Alzheimer 's disease : recommendations from the National Institute on Aging - Alzheimer 's Association workgroups on diagnostic guidelines for Alzheimer 's disease .", "label": "", "metadata": {}, "score": "55.553078"}
{"text": "Individuals at least 18 years of age who have completed 3 years in the IPPoMS trial .Design : .The first study visit for this trial will happen on the same day as the last visit for the IPPoMS trial .", "label": "", "metadata": {}, "score": "55.755867"}
{"text": "The P value column relates to association between study type ( longitudinal and cross - sectional studies ) and 1 ) Diagnostic criteria , 2 ) Setting , 3 ) Inclusion / exclusion criteria using Pearson 's chi squared tests .", "label": "", "metadata": {}, "score": "55.88165"}
{"text": "Clarke CE : A \" cure \" for Parkinson 's disease : can neuroprotection be proven with current trial designs ?Mov Disord 2004 , 19 ( 5 ) : 491 - 498 .", "label": "", "metadata": {}, "score": "55.996613"}
{"text": "( DOCX 289 KB ) .Competing interests .There are no conflicts of interest for any of the authors in relation to this manuscript .", "label": "", "metadata": {}, "score": "56.214306"}
{"text": "CSF biomarker values for each tertile are provided in the legend .Beta thalassemia major is a serious genetic disease of the blood .Treatments are limited , and although a bone marrow transplant from a compatible donor can be curative , only a limited percentage of individuals with this disease have a matched donor available .", "label": "", "metadata": {}, "score": "56.29992"}
{"text": "Sample size : A total of 24 subjects will be enrolled : 12 splenectomized participants and 12 non - splenectomized participants .End Points : This is a pilot study and no specific hypotheses are being tested .", "label": "", "metadata": {}, "score": "56.332584"}
{"text": "SPECT studies which use ligands to investigate cerebral blood flow are also grouped together .( SPECT , single - photon emission computed tomography ; PET , positron emission tomography ; MRI , magnetic resonance imaging ; FDOPA , [ 18 F]6-fluoro - L-3,4-dihydroxyphenylalanine ; FDG , [ 18 F]-2-fluoro-2-deoxyglucose ; DAT , dopamine active transporter ) .", "label": "", "metadata": {}, "score": "56.371727"}
{"text": "( 2005 , December 28 ) .New Study Demonstrates Combined Techniques To Detect , Monitor Alzheimer 's Disease .ScienceDaily .NIH / National Institute on Aging . \"", "label": "", "metadata": {}, "score": "56.650455"}
{"text": "Background .Biomarkers of disease progression in amyotrophic lateral sclerosis ( ALS ) could support the identification of beneficial drugs in clinical trials .We aimed to test whether soluble fragments of beta - amyloid precursor protein ( sAPPa and sAPP\u00df ) correlated with clinical subtypes of ALS and were of prognostic value .", "label": "", "metadata": {}, "score": "56.777542"}
{"text": "An improvement in diagnostic accuracy when adding a new test is often reported as area under the receiver - operator characteristics curve , which is hard to interpret ; the Net Reclassification Improvement ( NRI ) is an attractive and easy to interpret measure for clinicians .", "label": "", "metadata": {}, "score": "56.87416"}
{"text": "Prana tested both 50 mg and 250 mg once - daily doses of PBT2 in this study , which lasted three months .The researchers reported that the safety and tolerability of PBT2 at both doses were indistinguishable from placebo .", "label": "", "metadata": {}, "score": "56.99729"}
{"text": "It was supported by the National Institute on Aging ( NIA ) , a component of the National Institutes of Health ( NIH ) at the U.S. Department of Health and Human Services , and by the Washington University General Clinical Research Center , funded by the NIH .", "label": "", "metadata": {}, "score": "57.039787"}
{"text": "Gluud and Gluud 27 have made a plea for diagnostic test research that investigates if patients really fare better with a new test , after the test characterises of a new diagnostic method have been established .", "label": "", "metadata": {}, "score": "57.12107"}
{"text": "J Psychiatr Res 1975 , 12 ( 3 ) : 189 - 198 .PubMed View Article .Roth M , Tym E , Mountjoy CQ , Huppert FA , Hendrie H , Verma S , Goddard R : CAMDEX .", "label": "", "metadata": {}, "score": "57.19976"}
{"text": "( SPECT , single - photon emission computed tomography ; PET , positron emission tomography ; CSF , cerebrospinal fluid ; MRI , magnetic resonance imaging ; 123 I - MIBG , 123 I - metaiodobenzylguanidine ; MRS , magnetic resonance spectroscopy ) .", "label": "", "metadata": {}, "score": "57.70385"}
{"text": "However , clinical trials in neurodegenerative disorders have struggled to separate out symptomatic effects of potential therapeutic agents ( e.g. due to increased striatal dopamine ) from true disease - modifying effects .", "label": "", "metadata": {}, "score": "58.02733"}
{"text": "MRI often results in false - negative conclusions , that is , in patients who do have AD entorhinal cortex volumes are in the normal range .", "label": "", "metadata": {}, "score": "58.148796"}
{"text": "Table 3 .Baseline characteristics of study participants in the 183 included articles .Means are presented with standard deviations , and medians with interquartile ranges ( IQR ) .", "label": "", "metadata": {}, "score": "58.157516"}
{"text": "The change in CDR - SB over time was calculated for each tertile .The slope and intercept for each tertile are plotted for each biomarker : ( A ) CSF A\u03b2 42 , ( B ) CSF A\u03b2 40 , ( C ) CSF tau , ( D ) CSF ptau 181 , and ( E ) tau/", "label": "", "metadata": {}, "score": "58.271976"}
{"text": "UK Parkinson 's disease society .UPDRS : .Unified Parkinson 's disease rating scale .UPDRS ( I ) : .Mention behaviour and mood subsection of the UPDRS .", "label": "", "metadata": {}, "score": "58.556133"}
{"text": "The funders had no role in study design , data collection , data analysis , data interpretation , writing of the report or for the decision to submit for publication .", "label": "", "metadata": {}, "score": "58.688553"}
{"text": "29 , 30 The amyloid cascade hypothesis holds that AD starts with amyloid deposition decades before dementia symptoms appear .31 This process is revealed by low CSF A\u03b2 concentrations and high signal in A\u03b2 scanning with PET .", "label": "", "metadata": {}, "score": "58.758293"}
{"text": "References .Twelves D , Perkins KS , Counsell C : Systematic review of incidence studies of Parkinson 's disease .Mov Disord 2003 , 18 ( 1 ) : 19 - 31 .", "label": "", "metadata": {}, "score": "58.77131"}
{"text": "Following the development of a review protocol equivalent to the methodology described below , literature searches were conducted in the databases MEDLINE ( 1950 to August 2010 ) and Embase ( 1980 to August 2010 ) , using the OVID search interface .", "label": "", "metadata": {}, "score": "58.89218"}
{"text": "Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment .Archives of Neurology , 2011 ; 68 ( 6 ) : 743 - 752 DOI : 10.1001/archneurol.2011.125 .", "label": "", "metadata": {}, "score": "58.94471"}
{"text": "To determine whether Abeta 42 , tau , and ptau predict the rate of cognitive change in individuals with very mild dementia of the Alzheimer type ( DAT ) .", "label": "", "metadata": {}, "score": "59.137432"}
{"text": "Data used in preparation of this article were obtained from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) database ( adni.loni.ucla.edu ) .As such , the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report .", "label": "", "metadata": {}, "score": "59.191864"}
{"text": "After mobilization , participants will undergo a procedure called apheresis to remove the white blood cells .Researchers in the laboratory will purify the stem cells from the mixture and test methods of putting a normal globin gene into the stem cells .", "label": "", "metadata": {}, "score": "59.36712"}
{"text": "The slope and intercept for each tertile are plotted for each biomarker : ( A ) CSF A\u03b2 42 , ( B ) CSF A\u03b2 40 , ( C ) CSF tau , ( D ) CSF ptau 181 , and ( E ) tau/", "label": "", "metadata": {}, "score": "59.56006"}
{"text": "The mean age of participants in included studies was only 63.5 ( SD 5.6 ) years .Given that the median duration of disease at study entry was 5.7 ( IQR 3.6 to 7.4 ) years , these patients have fairly early onset disease .", "label": "", "metadata": {}, "score": "59.566006"}
{"text": "Validation of the electronic search strategy .The electronic search strategy was validated by hand searching five years of the two journals from which most of the included articles came : Movement Disorders ( 2002 - 2006 ) and Journal of the Neurological Sciences ( 1992 - 1996 ) .", "label": "", "metadata": {}, "score": "59.69585"}
{"text": "Table 5 .Comparison of the number of included longitudinal studies investigating a given biomarker modality with the number reporting a significant association between the biomarker modality and a clinical measure of disease progression .", "label": "", "metadata": {}, "score": "59.82921"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "60.077606"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "60.077606"}
{"text": "( 2009 , May 15 ) .Compounds In Spinal Fluid Associated With Faster Decline Among Individuals With Mild Dementia .ScienceDaily .JAMA and Archives Journals . \"", "label": "", "metadata": {}, "score": "60.17962"}
{"text": "Owing to its focus on the diagnosis of AD , participants with depression , cerebrovascular disease , major psychiatric disease and alcohol or substance abuse have been excluded while these conditions are certainly relevant to the differential diagnosis in clinical practice .", "label": "", "metadata": {}, "score": "60.350502"}
{"text": "PubMed View Article .Yamamoto M : Depression in Parkinson 's disease : its prevalence , diagnosis , and neurochemical background .J Neurol 2001 , 248 ( Suppl 3 ) : III5-III11 .", "label": "", "metadata": {}, "score": "60.405754"}
{"text": "Rascol O : \" Disease - modification \" trials in Parkinson disease : target populations , endpoints and study design .Neurology 2009 , 72 ( Suppl 7 ) : S51-S58 .", "label": "", "metadata": {}, "score": "60.51545"}
{"text": "The NRI is an intuitive and easy to interpret measure for evaluation of potential added value of new diagnostic instruments in daily clinical practice .Article summary .", "label": "", "metadata": {}, "score": "60.838577"}
{"text": "They will also receive a new supply of idebenone to take three times a day with food .They will keep a diary to report on any side effects .", "label": "", "metadata": {}, "score": "61.076233"}
{"text": "Study quality questionnaire based on the assay methods and study design sections of the REMARK reporting recommendations for prognostic tumour markers [ 18 ] .PD is a complex neurodegenerative disorder in which many different pathophysiological processes have been identified in the nigrostriatal pathways and beyond , such as protein aggregation , oxidative damage , mitochondrial dysfunction , lysosomal dysfunction and inflammation .", "label": "", "metadata": {}, "score": "61.088165"}
{"text": "PubMed View Article .Hughes AJ , Daniel SE , Kilford L , Lees AJ : Accuracy of clinical diagnosis of idiopathic Parkinson 's disease : a clinico - pathological study of 100 cases .", "label": "", "metadata": {}, "score": "61.394867"}
{"text": "The researchers behind the study hope that their findings will contribute to a ... read more Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type . 1 Department of Neurology , Washington University School of Medicine , Campus Box 8111 , 660 S Euclid , St Louis , MO 63110 , USA . sniderj@neuro.wustl.edu .", "label": "", "metadata": {}, "score": "61.89653"}
{"text": "Researchers want to give idebenone to all participants for 1 year .It is still not certain whether idebenone can slow the progression of multiple sclerosis , but this study may help answer that question .", "label": "", "metadata": {}, "score": "61.98654"}
{"text": "PubMed View Article .Taylor KS , Counsell CE , Harris CE , Gordon JC , Smith WC : Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen , United Kingdom : methods and preliminary results .", "label": "", "metadata": {}, "score": "62.326435"}
{"text": "The researchers used positron emission tomography ( PET ) , a brain imaging technique , with a tracing substance called Pittsburgh Compound B ( PIB ) , to determine the amount of plaques in the participants ' brains .", "label": "", "metadata": {}, "score": "62.36785"}
{"text": "To quantify the performance of test additions , we use the Net Reclassification Improvement ( NRI ) .i The NRI is simply the change in the percentage of individuals correctly diagnosed ( as AD or non - AD , in this study ) on the basis of any investigation that is added to the diagnostic information , that is , already available .", "label": "", "metadata": {}, "score": "62.58981"}
{"text": "DJMM reviewed the abstracts identified by the electronic search , extracted data from the full text of articles , and carried out the hand search .", "label": "", "metadata": {}, "score": "63.09382"}
{"text": "High CSF NfH SMI3 was linked to low CSF sAPPa and sAPP\u00df ( p ? 0.001 , and p ? 0.007 , respectively ) .The ratios CSF NfH SMI35 /CSF sAPPa,-\u00df were elevated in patients with fast progression of disease ( p ? 0.002 each ) .", "label": "", "metadata": {}, "score": "63.132835"}
{"text": "14 We selected entorhinal cortex volume ( part of the medial temporal lobe ) as the best discriminating MRI measure , based on the same previous analysis , which was recently confirmed by others .", "label": "", "metadata": {}, "score": "63.15455"}
{"text": "Introduction .Cognitive complaints are common in elderly populations and cognitive impairment and dementia are consistently rated among the top concerns by older persons .1 A timely and accurate diagnosis is important in patients presenting with cognitive complaints .", "label": "", "metadata": {}, "score": "63.2168"}
{"text": "How would you like to share ?Companies large and small are targeting amyloid - \u03b2 ( A\u03b2 ) , guided by the hypothesis that if they can decrease its concentration in the brain , then they will slow down disease .", "label": "", "metadata": {}, "score": "63.338196"}
{"text": "Fahn S , Eton RL : UPDRS Development Committee : The Unified Parkinson 's Disease Rating Scale .In Recent Developments in Parkinson 's Disease Volume 2 .", "label": "", "metadata": {}, "score": "63.453907"}
{"text": "Hepatitis B or C virus load negative by polymerase chain reaction ( PCR ) .Left ventricular ejection fraction ( LVEF ) greater than 45 % by echocardiogram or multiple gated acquisition scan ( MUGA ) .", "label": "", "metadata": {}, "score": "63.500164"}
{"text": "Abbreviations .[ 18 F]CFT : . 2\u03b2 - carbomethoxy-3\u03b2-(4- [ 18 F])-fluorophenyl ) tropane .[ 18 F]FP - CIT : .[ 18 F]-2\u03b2 - carbomethoxy-3\u03b2-(4-iodophenyl)-N-(3-fluoropropyl)-N - tropane .", "label": "", "metadata": {}, "score": "63.55486"}
{"text": "EXCLUSION CRITERIA : .Pregnant or lactating women .All women of child - bearing potential must have a negative pregnancy test .Patients dropping out of IPPoMS due to AEs considered related to study medication .", "label": "", "metadata": {}, "score": "63.591843"}
{"text": "Dietary changes appear to affect levels of biomarkers associated with Alzheimer 's disease .ScienceDaily .JAMA and Archives Journals . \"Dietary changes appear to affect levels of biomarkers associated with Alzheimer 's disease . \"", "label": "", "metadata": {}, "score": "63.614113"}
{"text": "The UK Parkinson 's Disease Society ( UKPDS )Brain Bank Criteria [ 9 ] was most commonly used to make the diagnosis of PD ( Table 2 ) , although a large proportion of studies simply used the presence of the cardinal clinical features of PD .", "label": "", "metadata": {}, "score": "63.748688"}
{"text": "Br J Psychiatry 1986 , 149 : 698 - 709 .PubMed View Article .Huber SJ , Paulson GW , Shuttleworth EC : Relationship of motor symptoms , intellectual impairment , and depression in Parkinson 's disease .", "label": "", "metadata": {}, "score": "64.638725"}
{"text": "Consensus report of the Working Group on : \" Molecular and Biochemical Markers of Alzheimer 's Disease \" : The Ronald and Nancy Reagan Research Institute of the Alzheimer 's Association and the National Institute on Aging Working Group .", "label": "", "metadata": {}, "score": "64.7849"}
{"text": "Background .Parkinson 's disease ( PD ) is the second most common progressive neurodegenerative disorder , with an annual incidence of around 16 - 19 cases per 100,000 [ 1 ] .", "label": "", "metadata": {}, "score": "64.908356"}
{"text": "JAMA and Archives Journals . \"Compounds In Spinal Fluid Associated With Faster Decline Among Individuals With Mild Dementia . \"ScienceDaily .ScienceDaily , 15 May 2009 . . .", "label": "", "metadata": {}, "score": "65.13054"}
{"text": "NIH / National Institute on Aging . \"New Study Demonstrates Combined Techniques To Detect , Monitor Alzheimer 's Disease . \"ScienceDaily .ScienceDaily , 28 December 2005 . . .", "label": "", "metadata": {}, "score": "65.26552"}
{"text": "In Applied mixed models in medicine .2nd edition .Chichester : J. Wiley ; 2006:215 - 270 .View Article .Pre - publication history .", "label": "", "metadata": {}, "score": "65.52989"}
{"text": "This drug is a so - called metal - protein interaction - attenuating compound ( MPAC ) , which reduces the interaction of amyloid with copper and zinc .", "label": "", "metadata": {}, "score": "65.80926"}
{"text": "Additionally , the LOW diet improved performance on delayed visual recall tests for both healthy and memory - impaired participants , but did not affect scores on other cognitive measures .", "label": "", "metadata": {}, "score": "66.06813"}
{"text": "Activities of daily living subsection of the UPDRS .UPDRS ( III ) : .Motor subsection of the UPDRS .Declarations .Acknowledgments .This article presents independent research funded by the National Institute for Health Research ( NIHR ) under its Programme Grants for Applied Research Programme ( Grant Reference Number RP - PG-0707 - 10124 ) .", "label": "", "metadata": {}, "score": "66.68266"}
{"text": "Other sources spoke off the record , but took the same stance.-Nadia Halim .Dietary changes appear to affect levels of biomarkers associated with Alzheimer 's disease .", "label": "", "metadata": {}, "score": "66.75384"}
{"text": "In the latter group , the LOW diet decreased some CSF biomarkers of AD as well as total cholesterol levels .However , among individuals with aMCI , the LOW diet increased levels of these biomarkers .", "label": "", "metadata": {}, "score": "67.47564"}
{"text": "The fragment is a major component of amyloid plaques in the brain , which are believed to influence cell - to - cell communication and are considered a hallmark of the Alzheimer 's brain .", "label": "", "metadata": {}, "score": "67.848015"}
{"text": "ER and WAvG have drafted the manuscript .BAS has contributed to the statistical analyses .ER , BAS , PE and WAvG are responsible for the intellectual content .", "label": "", "metadata": {}, "score": "68.430756"}
{"text": "In a four - week randomized , controlled trial , 24 participants followed the HIGH diet and 25 followed the LOW diet .The researchers studied participants ' performance on memory tests as well as their levels of biomarkers ( biological substances indicative of AD ) , such as insulin , cholesterol , blood glucose levels , blood lipid levels and components of cerebrospinal fluid ( CSF ) .", "label": "", "metadata": {}, "score": "69.53566"}
{"text": "Compounds In Spinal Fluid Associated With Faster Decline Among Individuals With Mild Dementia .Date : .Levels of biomarkers in the cerebrospinal fluid of individuals with very mild dementia may be associated with the rate at which their thinking , learning and memory skills decline , according to a new report .", "label": "", "metadata": {}, "score": "69.73547"}
{"text": "Altman DG : Relation between two continuous variables .In Practical Statistics for Medical Research .London : Chapman & Hall ; 1993:277 - 324 .", "label": "", "metadata": {}, "score": "70.65424"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT00336362 .Beta - Thalassemia Thalassemia Anemia Anemia , Hemolytic Anemia , Hemolytic , Congenital Genetic Diseases , Inborn Hematologic Diseases Hemoglobinopathies Hydroxyurea .", "label": "", "metadata": {}, "score": "70.84123"}
{"text": "The median total score produced by applying the adapted quality questionnaire to each of the included studies was 4.0 ( IQR 3.0 to 4.0 ) out of a possible six .", "label": "", "metadata": {}, "score": "71.39415"}
{"text": "Dietary changes appear to affect levels of biomarkers associated with Alzheimer 's disease . \"ScienceDaily .ScienceDaily , 14 June 2011 . . .JAMA and Archives Journals .", "label": "", "metadata": {}, "score": "71.44754"}
{"text": "The diagnosis was n't pretty and it may have caused ... read more .The results showed that those who ate the healthiest diet at the average age of 50 had an almost ... read more .", "label": "", "metadata": {}, "score": "71.560196"}
{"text": "Gene transfer involves obtaining blood stem cells from an individual , adding a normal globin gene to the stem cells , and putting the cells back into the individual .", "label": "", "metadata": {}, "score": "72.01557"}
{"text": "Health conditions in which insulin resistance ( the body 's inability to use insulin effectively ) is a factor -- obesity , type 2 diabetes , cardiovascular disease and high cholesterol levels -- have also been associated with \" pathological brain aging . \"", "label": "", "metadata": {}, "score": "72.10234"}
{"text": "In a cross - sectional study including patients with ALS ( N ? 68 ) with clinical follow - up data over 6 months , Parkinson 's disease ( PD , N ?", "label": "", "metadata": {}, "score": "72.1104"}
{"text": "PubMed View Article .Parkinson Study Group : Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression .JAMA 2002 , 287 ( 13 ) : 1653 - 1661 .", "label": "", "metadata": {}, "score": "72.33808"}
{"text": "Following a low - saturated fat and low - glycemic index diet appears to modulate the risk of developing dementia that proceeds to Alzheimer 's disease ( AD ) , although making a switch to this dietary pattern may not protect those already experiencing cognitive difficulty , according to a new study .", "label": "", "metadata": {}, "score": "72.67122"}
{"text": "The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada .The grantee organisation is the Northern California Institute for Research and Education , and the study is coordinated by the Rev August 16 2011 Alzheimer 's Disease Cooperative Study at the University of California , San Diego .", "label": "", "metadata": {}, "score": "73.093925"}
{"text": "Florham Park , New Jersey : Macmillan Healthcare Information ; 1987:153 - 163 .Folstein MF , Folstein SE , McHugh PR : \" Mini - mental state \" .", "label": "", "metadata": {}, "score": "74.096596"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT01854359 .Multiple Sclerosis Multiple Sclerosis , Chronic Progressive Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases , CNS Demyelinating Diseases Immune System Diseases .", "label": "", "metadata": {}, "score": "78.103195"}
{"text": "ScienceDaily .The excess mortality is especially pronounced among female ... read more .Body dysmorphic disorder ( BDD ) is a common anxiety disorder that causes a person ... read more .", "label": "", "metadata": {}, "score": "78.42703"}
{"text": "HU is used in splenectomized patients to attempt to reduce the risk of clotting during mobilization .In non - splenectomized patients , HU is given in an attempt to decrease the size of the spleen .", "label": "", "metadata": {}, "score": "84.33941"}
{"text": "The study found patients with COPD show regionally decreased ... read more .But do these differences influence coordination of ... read more .Brown adipose tissue ( BAT ) , also known as brown fat , is one of two types of ... read more .", "label": "", "metadata": {}, "score": "85.47225"}
{"text": "Weiner WJ , Lang AE : Parkinson 's disease .In Movement Disorders , A comprehensive survey .Edited by : Weiner WJ , Lang AE .", "label": "", "metadata": {}, "score": "87.67827"}
{"text": "Division of Applied Health Sciences , University of Aberdeen .Division of Health Sciences , University of Warwick .Centre for Health and Environmental Statistics , Plymouth University .", "label": "", "metadata": {}, "score": "89.293495"}
